MicroPort CardioFlow Medtech Corporation (HKG:2160)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.150
-0.030 (-0.95%)
Apr 20, 2026, 4:08 PM HKT
Market Cap4.01B +51.1%
Revenue (ttm)444.00M +15.2%
Net Income-146.48M
EPS-0.30
Shares Out1.27B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume311,400
Average Volume1,557,764
Open3.140
Previous Close3.150
Day's Range3.090 - 3.170
52-Week Range2.520 - 8.450
Beta0.45
RSI48.47
Earnings DateMar 30, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran... [Read more]

Sector Healthcare
Founded 2009
Employees 417
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2160
Full Company Profile

Financial Performance

In 2025, HKG:2160's revenue was $57.04 million, an increase of 15.16% compared to the previous year's $49.54 million. Losses were -$18.82 million, 177.8% more than in 2024.

Financial numbers in USD Financial Statements